Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 3(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07115641Not ApplicableNot Yet Recruiting

Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis

Role: collaborator

NCT06622304Completed

Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels

Role: collaborator

NCT01619176Not ApplicableCompleted

Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood

Role: collaborator

NCT05769712Unknown

A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity

Role: collaborator

NCT04875299Unknown

Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients

Role: collaborator

NCT03880968Completed

Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis

Role: collaborator

NCT04423276Phase 4Unknown

Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction

Role: collaborator

NCT02240901Not ApplicableCompleted

A Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients

Role: collaborator

NCT02927522Phase 3Unknown

Donepezil Attenuate Postoperative Cognitive Dysfunction

Role: collaborator

NCT02885597Phase 2Unknown

Juanbi Pill for Rheumatoid Arthritis

Role: collaborator

All 10 trials loaded